Phase II Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2017
At a glance
- Drugs Dianhydrogalactitol (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Del Mar Pharmaceuticals
- 06 Sep 2017 According to a DelMar Pharmaceuticals media release, update from the study will be presented at the 19th Annual Rodman & Renshaw Global Investment Conference 2017.
- 05 Apr 2017 Trial design presented at the 108th Annual Meeting of the American Association for Cancer Research
- 05 Apr 2017 Trial design presented at the American Association for Cancer Research (AACR) Annual Meeting 2017, according to a Delmar Pharmaceuticals, Inc. media release.